Same medicine. Same results.
Lower cost.
  • Biosimilars


    GPhA applauds Congress for establishing an abbreviated...
  • Drug Shortages

    As members of the public who also are affected by...
  • Quality

    Science and quality are the cornerstones of the generic...
  • Patent Settlements

    Patent Settlements

    GPhA vigorously opposes restricting the right of parties in...

    GPhA and its member companies support full implementation...


Improving Lives for Less

*New data* The 2015 Generic Drug Savings in the U.S. report shows that generic pharmaceuticals saved the U.S. health system $254 billion in 2014. For the first time, this year’s report features state-by-state savings, therapy area and public program savings and more. Data compiled by the IMS Institute for Healthcare Informatics. learn more >

Value and Quality

The Biosimilars Council

The Biosimilars Council, a division of
the Generic Pharmaceutical Association (GPhA), works to ensure a positive environment for patient access to biosimilar medicines.

Click here for more information.